Theodore Alan Huizenga
SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical · 7 reported transactions in 1 company · latest trade Sep 15, 2026
Their trades
Sold | Sep 15, 2026 | Sep 15, 2026 close $13.07 → Oct 29, 2026 close $16.78. S&P 500 +2.0% over the same days. | ||
Sold | Sep 3, 2026 | Sep 3, 2026 close $14.85 → Oct 29, 2026 close $16.78. S&P 500 −0.1% over the same days. | ||
Sold | Mar 2, 2026 | Mar 2, 2026 close $23.02 → Oct 29, 2026 close $16.78. S&P 500 +12.5% over the same days. | ||
Sold | Dec 29, 2025 | Dec 29, 2025 close $19.72 → Oct 29, 2026 close $16.78. S&P 500 +12.3% over the same days. | ||
Sold | Sep 18, 2025 | Sep 18, 2025 close $29.11 → Oct 29, 2026 close $16.78. S&P 500 +16.6% over the same days. | ||
Sold | Sep 5, 2025 | Sep 5, 2025 close $31.82 → Oct 29, 2026 close $16.78. S&P 500 +19.3% over the same days. |
$17.4K
Sep 15, 2026 close $13.07 → Oct 29, 2026 close $16.78. S&P 500 +2.0% over the same days.
$2.3K
Sep 3, 2026 close $14.85 → Oct 29, 2026 close $16.78. S&P 500 −0.1% over the same days.
$37.2K
Mar 2, 2026 close $23.02 → Oct 29, 2026 close $16.78. S&P 500 +12.5% over the same days.
$2.9K
Dec 29, 2025 close $19.72 → Oct 29, 2026 close $16.78. S&P 500 +12.3% over the same days.
$1.9K
Sep 18, 2025 close $29.11 → Oct 29, 2026 close $16.78. S&P 500 +16.6% over the same days.
$2.6K
Sep 5, 2025 close $31.82 → Oct 29, 2026 close $16.78. S&P 500 +19.3% over the same days.